Back to search results

Understanding Participation in Generalized Anxiety Disorder Clinical Trials

This study is looking to understand why people with Generalized Anxiety Disorder (GAD) choose to join or leave clinical trials. Researchers want to learn what factors encourage or discourage participation, and how these trends differ among various groups of people. The study will follow participants for up to 12 months to see how many stay in a clinical study until the end. You can join if you are 18 or older, have a confirmed GAD diagnosis, and are able to follow the study's requirements. This research doesn't involve any new treatments; instead, it aims to gather information to help improve future GAD studies.

Study design
This is an observational study planning to enroll 500 participants. It is not testing a new intervention.
What's involved
You must be willing and able to comply with scheduled visits, treatment schedules (if applicable), laboratory tests, and other study requirements.
Compensation
Not stated in the trial record.
Follow-up
The study will measure how many participants remain in a clinical study until completion, measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06254157

Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Not Yet Recruiting
Not specifiedAges 18+Observational
Power Life Sciences Inc.
~500 participants
Updated 2024-02-12 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of patients who decide to enroll in a generalized anxiety disorder clinical research.
Measured over 3 months
+1 more outcome measured

Conditions

Generalized Anxiety Disorder

Explore related trials

Generalized Anxiety Disorder

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.

Who to contact

Michael B Gill
[email protected]
4159004227
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Confirmed diagnosis of generalized anxiety disorder
Participant must be 18 years of age or older
Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.

Exclusion

Pregnant or lactating woman
Participant is actively receiving study therapy in another
Inability to provide written informed consent

What this trial measures

  • Rate of patients who decide to enroll in a generalized anxiety disorder clinical research.3 months
  • Number of generalized anxiety disorder study participants who remain in clinical study until completion.12 months